Depomed stock price

DEPO - Depomed Stock Profile - Barchart.com

DEPO interactive stock chart | Depomed, Inc. stock - Yahoo ... At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. NASDAQ:DEPO Depomed, Inc. Stock Analysis - CapitalCube Summary quote, performance, and fundamental analysis for NASDAQ:DEPO Depomed, Inc. Depomed, Inc. (delisted) Historical Data - DEPO | ADVFN Depomed, Inc. (delisted) (DEPO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Depomed Announces Corporate Governance Updates Nasdaq:ASRT

Why Depomed (DEPO) Stock Is Surging Today | Nasdaq

Apr 07, 2020 · Depomed, Inc. (NYSE:ASRT) shares rose 5.6% on Monday . The stock traded as high as $0.68 and last traded at $0.67, approximately 611,680 shares changed hands during mid-day trading. A decline of 67% from the average daily volume of 1,853,356 shares. The stock had previously closed at $0.63. Separately, Zacks Investment Research lowered Depomed from […] Assertio Therapeutics Inc., ASRT Quick Chart - (NAS) ASRT ... DepoMed stock price target raised to $8 from $6 at UBS MarketWatch. Monday, December 04, 2017. 05:04 PM ET. Depomed farms out Nucynta sales, will lay off 40% of company MarketWatch. 04:34 PM ET. Depomed to reduce staff by 40%, move headquarters out of California MarketWatch. 04:33 PM ET. DEPO - Depomed Stock Profile - Barchart.com Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. Price/Cash Flow - Latest closing price of the stock divided by the last twelve months revenue/cash flow per share. Price/Book - A financial ratio used to compare a company's current market price … Assertio Therapeutics Inc. Stock Price (ASRT) | Barron's

Depomed, Inc. (delisted) Stock Quote. DEPO - Stock Price ...

Why Depomed (DEPO) Stock Is Surging Today | InvestorPlace May 09, 2016 · Depomed’s full-year guidancce has been slightly altered, moving from in the range of $485 million to $525 million, to the range of $490 million to $520 million. DEPO stock is up 14.7% Monday DEPO — Stock Price and Discussion | Stocktwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Nov 05, 2019 · DepoMed stock price target raised to $8 from $6 at UBS. 10:24 a.m. Dec. 7, 2017 - Tomi Kilgore. Barron’s After Hours: Collegium Jumps, Ascena Retail Slumps, Cleveland-Cliffs Falls.

Apr 07, 2020 · Depomed, Inc. (NYSE:ASRT) shares rose 5.6% on Monday . The stock traded as high as $0.68 and last traded at $0.67, approximately 611,680 shares changed hands during mid-day trading. A decline of 67% from the average daily volume of 1,853,356 shares. The stock had previously closed at $0.63. Separately, Zacks Investment Research lowered Depomed from […]

Depomed, Inc. (delisted) Stock Chart - DEPO Oct 25, 2019 · Depomed, Inc. (delisted) (DEPO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. NASDAQ:DEPO Depomed, Inc. Stock Analysis - CapitalCube Depomed, Inc. manufactures and distributes pharmaceutical products. It is a specialty pharmaceutical company focused on the development and commercialization of products to treat pain and other central nervous system conditions. Depomed Inc. Stock Downgraded (DEPO) - TheStreet Aug 13, 2012 · NEW YORK ( TheStreet) -- Depomed (Nasdaq: DEPO) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net

Apr 05, 2017 · Depomed share price has declined significantly in 2017 as expectations for a buyer have failed to materialize.The negative market events, slowing Nucynta sales, … Depomed (NYSE:ASRT) Stock Price Up 5.6% - Redmond Register Apr 07, 2020 · Depomed, Inc. (NYSE:ASRT) shares rose 5.6% on Monday . The stock traded as high as $0.68 and last traded at $0.67, approximately 611,680 shares changed hands during mid-day trading. A decline of 67% from the average daily volume of 1,853,356 shares. The stock had previously closed at $0.63. Separately, Zacks Investment Research lowered Depomed from […] Assertio Therapeutics Inc., ASRT Quick Chart - (NAS) ASRT ... DepoMed stock price target raised to $8 from $6 at UBS MarketWatch. Monday, December 04, 2017. 05:04 PM ET. Depomed farms out Nucynta sales, will lay off 40% of company MarketWatch. 04:34 PM ET. Depomed to reduce staff by 40%, move headquarters out of California MarketWatch. 04:33 PM ET. DEPO - Depomed Stock Profile - Barchart.com Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. Price/Cash Flow - Latest closing price of the stock divided by the last twelve months revenue/cash flow per share. Price/Book - A financial ratio used to compare a company's current market price …